Education
About Us
Working with TipRanks
Follow Us
John J. Kirby Insider Profile
11 Followers
John J. Kirby, V.P., Chief Accounting Officer at Viropharma, holds 18.96K shares in Verrica Pharmaceuticals (Ticker: VRCA), holds 316.89K shares in Aceragen (Ticker: ACGN), holds 0.00 shares in Viropharma (Ticker: VPHM).
John J. Kirby Viropharma (VPHM)V.P., Chief Accounting Officer
Viropharma (VPHM)
V.P., Chief Accounting Officer
Ranked #76,352 out of 106,324 Corporate Insiders
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
-27.40%
Average return per transaction
Time Frame
Compare to
Insider Roles
Interim CFO
Roles that John J. Kirby holds in companies
Most Profitable Insider Trade
The most profitable trade made by John J. Kirby
John J. Kirby's Trading History
Viropharma
Jan 28, 2014
―
Uninformative Buy
―
―
Aceragen
Jan 10, 2023
―
Uninformative Buy
―
$120.42K
Verrica Pharmaceuticals
Dec 30, 2025
Interim CFO
Uninformative Buy
―
$113.39K
List of latest transactions for each holding click on a transaction to see John J. Kirby's performance on stock
You May Also Like
John J. Kirby insider profile FAQ
What is the percentage of profitable transactions made by John J. Kirby?
The percentage of profitable transactions made by John J. Kirby is 50%.
What is the average return per transaction made by John J. Kirby?
The average return per transaction made by John J. Kirby is -27.40%.
What stocks does John J. Kirby hold?
John J. Kirby holds: VPHM, ACGN, VRCA stocks.
What was John J. Kirby’s latest transaction?
John J. Kirby latest transaction was an Uninformative Buy of ―.
What was John J. Kirby's most profitable transaction?
John J. Kirby’s most profitable transaction was an Informative Buy of VRCA stock on November 25, 2025. The return on the trade was 3.70%.
What is John J. Kirby's role in Viropharma?
John J. Kirby's role in Viropharma is V.P., Chief Accounting Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.